Follow
adrian ishkanian
adrian ishkanian
Walker Family Cancer Center Niagara Health
Verified email at niagarahealth.on.ca
Title
Cited by
Cited by
Year
A tiling resolution DNA microarray with complete coverage of the human genome
AS Ishkanian, CA Malloff, SK Watson, RJ DeLeeuw, B Chi, BP Coe, ...
Nature genetics 36 (3), 299-303, 2004
7932004
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
E Lalonde, AS Ishkanian, J Sykes, M Fraser, H Ross-Adams, N Erho, ...
The lancet oncology 15 (13), 1521-1532, 2014
3222014
Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer
M Milosevic, P Warde, C Ménard, P Chung, A Toi, A Ishkanian, M McLean, ...
Clinical cancer research 18 (7), 2108-2114, 2012
2652012
Copy number alterations of c‐MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy
G Zafarana, AS Ishkanian, CA Malloff, JA Locke, J Sykes, J Thoms, ...
Cancer 118 (16), 4053-4062, 2012
1342012
High‐resolution array CGH identifies novel regions of genomic alteration in intermediate‐risk prostate cancer
AS Ishkanian, CA Mallof, J Ho, A Meng, M Albert, A Syed, ...
The Prostate 69 (10), 1091-1100, 2009
1012009
Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies
R Stoyanova, A Pollack, M Takhar, C Lynne, N Parra, LLC Lam, ...
Oncotarget 7 (33), 53362, 2016
952016
Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer
C Garnis, BP Coe, A Ishkanian, L Zhang, MP Rosin, WL Lam
Genes, Chromosomes and Cancer 39 (1), 93-98, 2004
852004
NKX3. 1 Haploinsufficiency Is Prognostic for Prostate Cancer Relapse following Surgery or Image-Guided RadiotherapyNKX3. 1 Is Prognostic for Prostate Cancer Outcome
JA Locke, G Zafarana, AS Ishkanian, M Milosevic, J Thoms, CL Have, ...
Clinical cancer research 18 (1), 308-316, 2012
542012
An efficient method for the assessment of DNA quality of archival microdissected specimens
A Siwoski, A Ishkanian, C Garnis, L Zhang, M Rosin, WL Lam
Modern pathology 15 (8), 889-892, 2002
542002
TMPRSS2-ERG Status Is Not Prognostic Following Prostate Cancer Radiotherapy: Implications for Fusion Status and DSB RepairTMPRSS2-ERG Status and Radiotherapy
A Dal Pra, E Lalonde, J Sykes, F Warde, A Ishkanian, A Meng, C Maloff, ...
Clinical Cancer Research 19 (18), 5202-5209, 2013
502013
Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma
CM McKee, D Xu, Y Cao, S Kabraji, D Allen, V Kersemans, J Beech, ...
The Journal of clinical investigation 122 (11), 4025-4036, 2012
502012
Upfront observation versus radiation for adult pilocytic astrocytoma
A Ishkanian, NJ Laperriere, W Xu, BA Millar, D Payne, W Mason, ...
Cancer 117 (17), 4070-4079, 2011
492011
Developing a predictive model for clinical outcomes of advanced non-small cell lung cancer patients treated with nivolumab
W Park, D Kwon, D Saravia, A Desai, F Vargas, M El Dinali, J Warsch, ...
Clinical lung cancer 19 (3), 280-288. e4, 2018
472018
Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer
AS Ishkanian, G Zafarana, J Thoms, RG Bristow
Acta oncologica 49 (7), 888-894, 2010
422010
NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer
A Berlin, E Lalonde, J Sykes, G Zafarana, KC Chu, VR Ramnarine, ...
Oncotarget 5 (22), 11081, 2014
352014
Radiation-Induced Enhancement of Antitumor T-cell Immunity by VEGF-Targeted 4-1BB CostimulationRadiation-Induced VEGF-Targeted 4-1BB Costimulation
B Schrand, B Verma, A Levay, S Patel, I Castro, AP Benaduce, ...
Cancer research 77 (6), 1310-1321, 2017
322017
Methods for high throughput validation of amplified fragment pools of BAC DNA for constructing high resolution CGH arrays
SK Watson, RJ DeLeeuw, AS Ishkanian, CA Malloff, WL Lam
BMC genomics 5 (1), 1-8, 2004
322004
Posterior sternoclavicular joint dislocation: case report and discussion
N Kuzak, A Ishkanian, RB Abu-Laban
Canadian Journal of Emergency Medicine 8 (5), 355-357, 2006
132006
4-1BB aptamer-based immunomodulation enhances the therapeutic index of radiation therapy in murine tumor models
AP Benaduce, R Brenneman, B Schrand, A Pollack, E Gilboa, A Ishkanian
International Journal of Radiation Oncology* Biology* Physics 96 (2), 458-461, 2016
112016
Neoadjuvant radiotherapy improves survival in patients with T2b/T3 bladder cancer: a population-based analysis
DA Diaz, A Pollack, IM Reis, O Mahmoud, ML Gonzalgo, A Ishkanian, ...
Clinical genitourinary cancer 13 (4), 378-384. e1, 2015
92015
The system can't perform the operation now. Try again later.
Articles 1–20